PeptiDream Inc (PPTDF)
12.00
-1.75
(-12.73%)
USD |
OTCM |
May 17, 09:30
PeptiDream Total Assets (Quarterly): 460.09M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 460.09M |
December 31, 2023 | 492.57M |
September 30, 2023 | 442.50M |
June 30, 2023 | 398.51M |
March 31, 2023 | 448.62M |
December 31, 2022 | 487.10M |
September 30, 2022 | 354.81M |
June 30, 2022 | 379.93M |
March 31, 2022 | 426.89M |
December 31, 2021 | 234.93M |
September 30, 2021 | 249.20M |
June 30, 2021 | 219.50M |
March 31, 2021 | 218.96M |
December 31, 2020 | 254.68M |
September 30, 2020 | 180.05M |
June 30, 2020 | 183.68M |
March 31, 2020 | 165.32M |
September 30, 2019 | 173.06M |
June 30, 2019 | 185.73M |
March 31, 2019 | 149.63M |
December 31, 2018 | 147.06M |
September 30, 2018 | 139.19M |
Date | Value |
---|---|
June 30, 2018 | 149.31M |
March 31, 2018 | 115.14M |
December 31, 2017 | 109.84M |
September 30, 2017 | 111.29M |
June 30, 2017 | 121.65M |
March 31, 2017 | 98.80M |
December 31, 2016 | 96.24M |
September 30, 2016 | 114.67M |
June 30, 2016 | 116.30M |
March 31, 2016 | 90.79M |
December 31, 2015 | 62.60M |
September 30, 2015 | 59.33M |
June 30, 2015 | 63.07M |
March 31, 2015 | 50.19M |
December 31, 2014 | 50.59M |
September 30, 2014 | 54.57M |
June 30, 2014 | 59.15M |
March 31, 2014 | 57.91M |
December 31, 2013 | 57.23M |
September 30, 2013 | 59.52M |
June 30, 2013 | 60.17M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
165.32M
Minimum
Mar 2020
492.57M
Maximum
Dec 2023
313.48M
Average
254.68M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 99.82B |
Nxera Pharma Co Ltd | 1.006B |
Healios KK | 108.91M |
AnGes Inc | 185.19M |
SanBio Co Ltd | 34.25M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 195.91M |
Shareholders Equity (Quarterly) | 264.18M |
Debt to Equity Ratio | 0.5396 |
Current Ratio | 3.502 |
Net Debt Paydown Yield | 0.29% |